Skip to main content

Web Exclusives

FDA Updates

Sustol, First Extended-Release 5-HT3 Approved for the Prevention of CINV

FDA Updates

Cabometyx Receives FDA Approval for Advanced Renal-Cell Carcinoma

FDA Updates

Olaratumab Approved for Use with Doxorubicin in Adults with Advanced Soft-Tissue Sarcoma

FDA Updates

Atezolizumab First PD-L1 Inhibitor Approved for the Treatment of Patients with Metastatic NSCLC

FDA Updates

Pembrolizumab Approved for Patients with Head and Neck Cancer

FDA Updates

Monthly Injection Approved for Patients with Relapsed Multiple Sclerosis

FDA Updates

Netspot Approved for Detection of Neuroendocrine Tumors

FDA Updates

First EGFR Mutation Blood Test Approved for Patients with NSCLC

From the Literature

Concise Reviews of Studies Relevant to Hematology Oncology Pharmacy

FDA Updates

Atezolizumab Approved for Patients with Advanced or Metastatic Urothelial Carcinoma

Page 32 of 43
Results 311 - 320 of 425